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ABSTRACT
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a recently described auto-immune and paraneoplastic 
encephalitis with prominent neuropsychiatric manifestations affecting young adults with ovarian teratoma. The availability 
of a novel assay to measure these antibodies might suggest an etiology for this potentially life-threatening disease, 
which if early recognized can be treated promptly with surgery with chances of a good clinical outcome. Reported 
prognostic indicators for a good outcome depend on the presence of a tumor, prompt treatment and no admission 
to an intensive care unit. However, due to the rarity and unawareness of this disease, the diagnosis may be delayed as 
primary psychiatric disorders, and infective encephalitis is taken more into consideration and ruled out first. Here we 
report a case of anti-NMDAR encephalitis in a 22-year-old female prompted by an ovarian teratoma with a gradual and 
complete resolution of symptoms after surgical excision of the teratoma and immunomodulating therapies. 
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INTRODUCTION
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) 
encephalitis is an auto-immune and paraneoplastic 
encephalit is with prominent neuropsychiatr ic 
manifestations. The N-methyl-D-aspartate receptor is 
located in the forebrain and hippocampus and plays 
a role in learning and memory. In this disease, the 
NR1 subunit of the NMDA receptors is targeted by 
antibodies resulting in internalization of NMDAR and 
progressive decline of NMDAR-associated synaptic 
functions resulting in neurological and psychiatric 
manifestations.1,2 Anti-NMDAR encephalitis was first 
described in 1997 in two isolated case reports of 
young females with ovarian teratomas presenting 
with psychiatric manifestations and altered level of 
consciousness who subsequently showed substantial 
improvement in clinical symptoms after tumor 
removal.3,4 In the following years, a handful of cases 
affecting both men and women have been reported 
in the literature with the majority of the cases (80%) 
linked with women.5 The average age of onset of 
symptoms is 21 years, although cases have been 
described in patients ranging from 8 months to 
85 years.2,6,7 It was recently described that anti-NMDAR 
encephalitis is the more frequent cause of encephalitis 
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in patients younger than 30 years as compared to 
viral encephalitis caused by herpes, West-Nile and 
Varicella-Zoster.8 Outcomes differ from full recovery 
to 24-hour institutional care, to death after prolonged 
hospitalization.9-11 Early surgical excision of the 
teratoma, with no need for intensive care admission, 
results in a better outcome with fewer relapses.1,10,12 
Nevertheless, a fourth of the patients have a grave 
clinical outcome with severe disability and death. 
Estimated mortality has been reported about 7%.10
In this case report, we describe a 22-year-old 
previously healthy female presenting with a month 
history of mood lability, psychosis with progressive 
bradykinesia who found to have anti-NMDAR 
encephalitis associated with ovarian teratoma.
CASE REPORT
This patient is a 22-year-old female with no 
significant past medical history presented to the 
emergency room with the chief complaints of altered 
mental status, acute psychosis with suicidal ideation, 
decreased oral intake and reduced urine output. 
Her mother indicated that the patient has been having 
“mood swings”, anxiety, depression and progressing 
slow body movement for 3 weeks before admission. 
The mother contributed her behavior to her recent 
estranged relationship with her boyfriend, so they did 
not seek any medical advice at that time. On the day 
of admission, the patient was found to be agitated, 
and she attempted suicide by trying to jump out of 
the car on the freeway. She was then brought to our 
facility for medical care.
When the patient arrived at the hospital, she 
was placed on an involuntary hold by a psychiatrist. 
During that time patient was noted to be delirious, 
uncooperative, agitated, demanding, and impulsive and 
displayed aggressive behavior. Initial imaging did not 
show acute intracranial abnormalities. She was started 
on sodium valproate for a presumed bipolar disorder 
with psychotic features in addition to olanzapine and 
clonazepam. Following her ED visit, the patient was 
admitted by the Internal Medicine team to the Medical 
ICU. Neurologic exam was unable to be completed due 
to her agitation, confusion, and uncooperativeness. 
However cranial nerve II-XII strength and sensation 
appeared grossly intact. Her working diagnosis at this 
time was considered to be encephalopathy (including 
viral, fungal, bacterial, spirochetal, toxoplasmal, 
paraneoplastic antibodies, anti-NMDAR encephalitis), 
sepsis vs systemic inflammatory response syndrome 
(SIRS) from aspiration and acute hypoxic respiratory 
failure, due to her oxygen level desaturations. She had 
an extensive infectious, metabolic, autoimmune, and 
neurologic workup.
The initial panels have returned negative. 
However, her central nervous system fluid (CSF) 
differential showed a high white blood cell (WBC) 
count (14.4/mm3) with lymphocytic pleocytosis. Protein 
and glucose levels were normal. The preliminary 
HSV type 1 and type 2 PCR results were negative; 
the patient was started with acyclovir 500 IV q8h 
empirically. However, it was discontinued as soon as 
her final HSV type 1 and type 2 PCR report also came 
back negative.
Further investigation showed elevated titers of 
anti-NMDA antibodies evaluated by Enzyme-Linked 
Immunosorbent Assay. Anti-NMDA antibodies were 
detected in both serum (1:160) and CSF (1:80). 
Two brains images were done during patient’s 
hospitalization including a brain magnetic resonance 
imaging (MRI) (with and without contrast) and a brain 
computed tomography (CT) without contrast. Routine 
electroencephalogram (EEG) was done following 
admission followed by continued EEG monitoring 
throughout admission.
The patient was started on intravenous (IV) 
steroids, IV immunoglobulin (IVIG) and plasma 
exchange and gynecology was consulted for further 
workup as for possible associated ovarian teratoma. 
The pelvic MRI revealed bilateral ovarian cysts, which 
measured 1.7 cm on the right ovary and 6.4 cm on the 
left ovary (Figure 1). The images appeared to be more 
consistent with a dermoid cyst or hemorrhagic cyst.
Ovarian Teratoma
She underwent a right salpingo-oophorectomy 
and left ovarian cystectomy. The left ovarian cyst 
measured 8.0 cm in its greatest dimension with tan 
brown smooth cyst wall containing dark reddish brown 
adherent blood clot that histologically revealed an 
endometroid cyst. The right ovary measured 4.2 cm 
in its greatest dimension with multiple unilocular cysts 
ranging from 0.2 to 0.6 cm. There was also a tan-gray 
1.4 cm solid area within the ovary, which has a fleshy 
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cut surface with attached dark brown hair. On the 
histology, the mass in the right ovary revealed a mature 
cystic teratoma (Figure 2).
The teratoma contained neural elements 
resembling white matter. The immunohistochemical 
stain confirmed that the neural component strongly 
expressed glial f ibri l lary acidic protein (GFAP) 
(Figure 3A) and S100. Aggregates of mature-appearing 
lymphocytes were noted adjacent to the neural tissue 
(Figure 3B), stained positive with CD45 (Figure 3C). 
Approximately 80% of these lymphocytes expressed 
PAX-5, and therefore these cells were of B-cell lineage 
(Figure 3D).
The patient was started on high dose steroids 
(dexamethasone 10 mg three times a day IV) with 
gradual taper in the next three months post-surgery, 
intravenous immunoglobulins (IVIG) 2 rounds (with one 
month interval) of 10% IVIG 17.5 g, and repeated 
cycles of plasma exchange with gradual improvement 
in symptoms three weeks’ post-surgery as evidenced 
by restoration of sleep-wake cycles, increased the 
frequency of alertness, ability to more consistently 
follow commands, decreased the frequency of fevers, 
improvement of blood pressure and tachycardia. 
Finally, after two and half month’s post-surgery she was 
discharged with full return of function. She returned for 
follow up six months after surgery, before returning to 
college, this time she reported feeling that her memory 
and movement had improved and she felt more like her 
normal self. Her neurological and psychiatric workup 
was completely within normal, and it was considered 
that she did not need future treatment or follow-up 
as she was completely recovered.
DISCUSSION
First described in 1997 by Dalmau et al. in two 
isolated case reports, anti-NDMAR encephalitis is a 
potentially life-threatening condition with a wide 
spectrum of symptoms.1 The initial prodromal phase is 
a nonspecific viral-like symptom disease with headache, 
nausea, vomiting, fever, and fatigue, which later on 
progresses rapidly into two stages of neuropsychiatric 
abnormalities.2 The early stage symptoms include 
confusion, memory loss, paranoia, hallucinations, 
mood disturbances, anxiety, self-harming behaviors, 
seizures and dyskinesia such as facial twitching and 
choreoathetosis. Due to the predominance of the 
psychiatric symptoms at this stage, the majority of 
these patients consult psychiatrists initially,5 and many 
of them are misdiagnosed with new-onset psychiatric 
disorders and are started on anti-psychotics. However, 
these patients do not respond to these drugs and 
rapidly progress to late-stage symptoms of decreased 
Figure 1. Pelvic MRI scan (T2 weighted image) in the 
sagittal plane showing the right.
Figure 2. Tissue section of right ovary showing mature 
neural and epithelial elements intermixed with mature 
lymphocytes (H&E, 10X). Note epithelial elements 
(arrowheads), lymphocytes (arrow) and neural elements 
(asterisk).
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responsiveness, hypoventilation, and autonomic 
instability manifesting as hypotension or hypertension, 
bradycardia or tachycardia, hyperthermia, and urinary 
incontinence.
Although cases have been reported in patients 
ranging from 8 months to 85 years old,2,6 the disease 
mostly affects young adults with a median age of 
21 years. Most of the patients are between the ages 
12 and 45 years old with Asian or African American 
descent, and present with an associated teratoma.2,6 
Only 9% of the patients younger than 14 years had 
accompanying teratomas.7 Most commonly, the tumors 
are located in the ovary; however, rarely mediastinal 
teratomas have also been implicated.9 Reports have 
also suggested that anti-NMDAR encephalitis can also 
be related to other germ-cell and rarely non-germ cell 
tumors.2,6,9
Previous studies conjectured that the syndrome 
was a paraneoplastic process due to an antibody to an 
unidentified antigen expressed in the hippocampus.13 
In 2007, the associated antibody was discovered to 
be the anti-NMDA-receptor.9 In this disease process, 
antibodies are generated in response to the neural 
elements within the teratoma. The newly formed 
autoantibodies react with the NMDA Receptor 1 (NR1) 
subunit of the ligand-gated cation channels NMDA 
receptor that is primarily expressed in the hippocampus 
and forebrain, which are implicated in memory and 
learning.14
Figure 3. A – Tissue section from the right ovarian teratoma showing neural tissue strongly expressing the glial 
fibrillary acidic protein (GFAP, 50X) (asterisk); B – aggregates of mature-appearing lymphocytes adjacent to neural 
tissue (H&E, 50X) (arrow); C – The lymphocytes were positive for CD 45 in (50X) (arrows); and D – The lymphocytes 
were also positive for PAX5 (50X) (arrows).
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Occasionally this syndrome has been associated to 
patients with no detectable underlying neoplasms where 
it is theorized that the syndrome may be triggered by 
microscopic germ cell tumors undetectable by imaging 
diagnostic methods.5 This hypothesis is supported by 
the findings that these group of patients established 
clinical responses to immunomodulatory regimens, 
including steroids, intravenous immunoglobulin, and 
plasmapheresis.7,10 Moreover, it has been reported 
that ovarian teratomas were detected years after the 
presentation of anti-NMDAR encephalitis symptoms.5
Here we present a case of a young female who 
presented with typical neuropsychiatric symptoms 
and was diagnosed with paraneoplastic anti-NMDA 
receptor encephalitis. Our patient was diagnosed 
within 24 hours after admission, and her ovarian 
teratoma was removed approximately 6 weeks after 
the onset of symptoms. Despite this rapid intervention, 
she did not start to improve until 3 weeks later. Finally, 
after two and half months of hospital course with 
immunosuppressive drugs, plasma exchanges, she 
was discharged with full return of function. In our 
case as well as in other reported cases, the symptoms 
of anti-NMDAR encephalitis evidently improved within 
a month of tumor removal and immunosuppressive 
treatment. However, recovery can continue for up 
to 2 years.2,6 Gradual improvement with periods of 
relapse seemed to be a distinctive of anti-NMDA 
encephalitis, likely because of the failure of common 
immunomodulatory therapies to provide persistent 
control of the immune response.1
Diagnosis of encephalitis should be considered 
in patients with acute onset of neuropsychiatric 
symptoms unresponsive to antipsychotic medications. 
Serum and CSF studies for viral and autoimmune causes 
of encephalitis, MRI, and EEG should be performed to 
obtain a specific diagnosis. It is important to note that 
although brain MRI may be within normal limits in 67% 
of patients, 90% of these patients commonly show 
EEG abnormalities.6 The final diagnosis is made with 
the detection of anti-NMDAR antibodies in the blood 
or CSF.2,6 The conclusive diagnosis of anti-NMDAR 
encephalitis should prompt further imaging studies 
such as pelvic ultrasound, MRI, CT, and positron 
emission tomography to evaluate for an underlying 
teratoma. In rapidly decompensating patients with a 
clinical suspicion of anti-NMDAR encephalitis, imaging 
and removal of any detected neoplasms should be 
considered without delay, as in this case. Any delay 
in treatment may result in deterioration of the 
autoimmune process with progression to autonomic 
instability, catatonia, status epilepticus, or coma and 
even death.6 The majority of the patients who undergo 
surgical excision of the tumor and immunosuppressive 
treatment are found to have a significant improvement 
in the neurologic status2 and a decrease in both 
serum and cerebrospinal fluid levels of the pathologic 
autoantibody.11 The main immunosuppressive therapies 
commonly used include intravenous steroids and IVIG 
or plasmapheresis as the first line with rituximab and 
cyclophosphamide as the second line.2,6
It is clinically relevant to note that NMDAR-antibodies 
can be produced after post-herpetic encephalitis.15 
According to a recently published report in 2017,16 
about one-fourth (26%) of patients with newly 
diagnosed Herpes simplex encephalitis went on to 
develop post-herpetic encephalitis and amongst them, 
a majority of the patients (86%) showed antibodies to 
neuronal antigens and the most commonly detected 
antibodies were anti-NMDAR antibodies (71%).
To conclude, awareness and diagnosis of 
anti-NMDAR encephalitis are of extreme importance 
to pediatricians, and gynecologists as well as to the 
general practitioner and psychiatrist as complete 
recovery after surgical resection is possible despite 
the severity of symptoms. Young patients presenting 
with neuropsychiatric symptoms are occasionally 
misdiagnosed with psychiatric illness or viral encephalitis. 
A simple yet reliable measure of autoantibody titers, 
as well as clinical suspicion of and ovarian teratoma, 
would benefit an increasing number of patients 
from prompt diagnosis and treatment of this novel 
difficult-to-treat clinical entity.
The manuscript is in accordance with the 
Institutional Ethics committee requirements.
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